MedTrace Logo

Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

NCT03532724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 927

Last updated 2019-03-01

No results posted yet for this study

Summary

ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain)

Conditions

  • Self Management of Oral Anticoagulation With VKA Therapy

Interventions

DEVICE

Patient Self-Management of VKA therapy

Trained patients check weekly the INR using a portable coagulometer an decide by themselves the dosis of VKA

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Juan C Souto, MD, PhD · Hospital de la Santa creu i Sant Pau - Barcelona

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-07-30
Completion
2018-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03532724 on ClinicalTrials.gov